Literature DB >> 1687874

Synergism between alpha 1-blockade and angiotensin converting enzyme inhibition in essential hypertension.

M J Brown1, J E Dickerson.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1687874

Source DB:  PubMed          Journal:  J Hypertens Suppl        ISSN: 0952-1178


× No keyword cloud information.
  4 in total

Review 1.  Matching the right drug to the right patient in essential hypertension.

Authors:  M J Brown
Journal:  Heart       Date:  2001-07       Impact factor: 5.994

2.  A clinical pharmacological assessment of doxazosin and enalapril in combination.

Authors:  A D Bainbridge; P A Meredith; H L Elliott
Journal:  Br J Clin Pharmacol       Date:  1993-12       Impact factor: 4.335

Review 3.  Doxazosin. An update of its clinical pharmacology and therapeutic applications in hypertension and benign prostatic hyperplasia.

Authors:  B Fulton; A J Wagstaff; E M Sorkin
Journal:  Drugs       Date:  1995-02       Impact factor: 9.546

4.  Doxazosin gastrointestinal therapeutic system: a clinical perspective.

Authors:  Samuel J Mann
Journal:  J Clin Hypertens (Greenwich)       Date:  2006-03       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.